MMP9 and Cerebral ischemia: Despite the prominent role of MMP-9 and MMP-3 in BBB disruption in cerebral ischemia, therapeutic targeting of these proteases in humans is challenging because current pharmacological inhibitors produce a complete and unspecific inhibition of all members of the MMP family which results in unfavorable side effects and limits their clinical use61.